Nuria Lapena - Grifols SA Director of Shareholder and Investor Relations
| GIFLF Stock | USD 8.46 0.00 0.00% |
Director
Nuria Lapena is Director of Shareholder and Investor Relations of Grifols SA since 2015.
| Tenure | 9 years |
| Phone | 34 93 571 02 21 |
| Web | https://www.grifols.com |
Grifols SA Management Efficiency
The company has return on total asset (ROA) of 0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0182 %, meaning that it generated $0.0182 on every $100 dollars invested by stockholders. Grifols SA's management efficiency ratios could be used to measure how well Grifols SA manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michael Eskew | Eli Lilly and | 71 | |
| Carolyn Bertozzi | Eli Lilly and | 53 | |
| David Hoover | Eli Lilly and | 72 | |
| Mary Beckerle | Johnson Johnson | 66 | |
| Ann Fudge | Novartis AG ADR | 70 | |
| Ellen Marram | Eli Lilly and | 71 | |
| William Kaelin | Eli Lilly and | 63 | |
| Graham Chipchase | AstraZeneca PLC ADR | 54 | |
| Nancy Andrews | Novartis AG ADR | 63 | |
| Elizabeth Doherty | Novartis AG ADR | 64 | |
| Philip Broadley | AstraZeneca PLC ADR | 52 | |
| Nazneen Rahman | AstraZeneca PLC ADR | N/A | |
| John Noseworthy | Merck Company | 66 | |
| William Harrison | Merck Company | 70 | |
| Beatrice Mauro | Roche Holding Ltd | 49 | |
| Michel Demare | AstraZeneca PLC ADR | 62 | |
| Franklyn Prendergast | Eli Lilly and | 70 | |
| Kathy Warden | Merck Company | 49 | |
| Julie Brown | Roche Holding Ltd | 56 | |
| Patricia Russo | Merck Company | 68 | |
| JeanPhilippe Courtois | AstraZeneca PLC ADR | 54 | |
Management Performance
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 |
Grifols SA Leadership Team
Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Antonio Pares, Director of Planning and Control | ||
| Peter Allen, Chairman of Hospital OPS Division | ||
| Carsten Schroeder, President Of The Diagnostic Division | ||
| Albert Roura, CEO of Laboratorios Grifols SA | ||
| Jose Garcia, Director General De Laboratorios Grifols | ||
| Lafmin Morgan, President Of The Bioscience And Hospital Division | ||
| Juan Roura, Vice President of Production, Executive Director | ||
| Eva Tubau, Chief Scientific Officer | ||
| Anna Lluch, Independent Director | ||
| Carlos Fernandez, Deputy Industrial Vice President | ||
| Jose Gras, Director, Representative of Thorthol Holdings BV | ||
| Maria Llano, Chief Officer | ||
| Edgar Jannotta, Independent Director | ||
| Vicente Torre, CTO | ||
| Mateo Humbert, Director of Human Resources | ||
| Montserrat Calvo, Chief Administrative Officer, Controller | ||
| Montserrat Llamas, Chief Officer | ||
| Ramon Roca, Vice-President of Marketing and Sales and Executive Director | ||
| Vctor Deu, CoCEO Director | ||
| David Bell, Vice President of Corporate Operations and Development of Grifols Inc and United States Subsidiaries | ||
| Victor Deu, Co-CEO, Executive Director | ||
| Luis Bobadilla, Independent Director | ||
| Inigo Mardones, Director | ||
| Thomas Glanzmann, Director | ||
| Carina Lazaro, Independent Director | ||
| Joel Abelson, President of North America Commercial Division of Grifols Inc | ||
| Steven Mayer, Director | ||
| Jose Fulla, CEO of Diagnostic Industrial Group | ||
| Javier Ribes, CEO of Instituto Grifols SA | ||
| Alfredo Guerra, CFO and Corporate VP | ||
| Raimon Roura, Non-Member Secretary of the Board | ||
| Miguel Montblanch, Chariman of Global Operations Network | ||
| Victor Roura, Chairman, CEO and President and Member of Appointments and Remuneration Committee | ||
| Brett Ingersoll, Director | ||
| Shinji Wada, President of Plasma Centers of Grifols Inc | ||
| Tomas Gelabert, Director | ||
| Nuria Lapea, Risk Treasury | ||
| M Tubau, Co Affairs | ||
| Steven JD, Ex Chairman | ||
| Marla Salmon, Independent Director | ||
| Nuria Barnes, Non-Member Assistant Secretary of the Board | ||
| Gregory Rich, President of Grifols Inc and Subsidiaries in the US | ||
| Belen Morenes, Independent Director | ||
| Nuria Lapena, Director of Shareholder and Investor Relations |
Grifols Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Grifols SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0182 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 16.07 B | |||
| Shares Outstanding | 422.18 M | |||
| Shares Owned By Insiders | 30.57 % | |||
| Shares Owned By Institutions | 30.49 % | |||
| Price To Earning | 9.52 X | |||
| Price To Book | 1.04 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Grifols SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Grifols SA's short interest history, or implied volatility extrapolated from Grifols SA options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grifols SA. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for Grifols Pink Sheet analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |